2018
DOI: 10.1007/s10517-018-3992-2
|View full text |Cite
|
Sign up to set email alerts
|

Cellular Mechanisms of Aortic Valve Calcification

Abstract: Comparative in vitro study examined the osteogenic potential of interstitial cells of aortic valve obtained from the patients with aortic stenosis and from control recipients of orthotopic heart transplantation with intact aortic valve. The osteogenic inductors augmented mineralization of aortic valve interstitial cells (AVIC) in patients with aortic stenosis in comparison with the control level. Native AVIC culture of aortic stenosis patients demonstrated overexpression of osteopontin gene (OPN) and underexpr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 13 publications
0
6
0
1
Order By: Relevance
“…It is known that OPN intensively stains calcified regions in sclerotic aortic valves [ 57 , 58 ] but the functional role of OPN in CAVD is still controversial. OPN may bind to apatite crystals and is considered as a potential mineralization inhibitor [ 59 ] though at the same time OPN expression increases with the progression and calcification in human aortic valve tissue [ 60 ] suggesting a pro-degenerative role.…”
Section: Discussionmentioning
confidence: 99%
“…It is known that OPN intensively stains calcified regions in sclerotic aortic valves [ 57 , 58 ] but the functional role of OPN in CAVD is still controversial. OPN may bind to apatite crystals and is considered as a potential mineralization inhibitor [ 59 ] though at the same time OPN expression increases with the progression and calcification in human aortic valve tissue [ 60 ] suggesting a pro-degenerative role.…”
Section: Discussionmentioning
confidence: 99%
“…To date, there have been no effective medications to prevent valvular calcification. Statins and angiotensin‐converting enzyme inhibitors have been highly hopeful, but many of their large clinical trials have confirmed that neither treatment can effectively slow the progression of this disease (Zhiduleva et al, ). Currently, a reasonable daily diet or health care food supplements may be the most effective way to suppress CHVD progress.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, there are no effective preventive measures to treat CHVD, given that the underlying mechanisms of the disease are not very well understood. Statins and ACE inhibitors have been highly hopeful, but many of their large clinical trials have confirmed that neither treatment can effectively slow the progression of this disease ( Zhiduleva et al, 2018 ).…”
Section: Introductionmentioning
confidence: 99%